Multidimensional endotyping in patients with severe asthma reveals inflammatory heterogeneity in matrix metalloproteinases and chitinase 3–like protein 1
Disease heterogeneity in patients with severe asthma and its relationship to inflammatory mechanisms remain poorly understood.We aimed to identify and replicate clinicopathologic endotypes based on analysis of blood and sputum parameters in asthmatic patients.One hundred ninety-four asthmatic patien...
| Main Authors: | , , , , , , , , , , , , , |
|---|---|
| Format: | Journal article |
| Language: | English |
| Published: |
Elsevier
2016
|
| _version_ | 1797069443439788032 |
|---|---|
| author | Hinks, T Brown, T Lau, L Rupani, H Barber, C Elliott, S Ward, J Ono, J Ohta, S Izuhara, K Djukanović, R Kurukulaaratchy, R Chauhan, A Howarth, P |
| author_facet | Hinks, T Brown, T Lau, L Rupani, H Barber, C Elliott, S Ward, J Ono, J Ohta, S Izuhara, K Djukanović, R Kurukulaaratchy, R Chauhan, A Howarth, P |
| author_sort | Hinks, T |
| collection | OXFORD |
| description | Disease heterogeneity in patients with severe asthma and its relationship to inflammatory mechanisms remain poorly understood.We aimed to identify and replicate clinicopathologic endotypes based on analysis of blood and sputum parameters in asthmatic patients.One hundred ninety-four asthmatic patients and 21 control subjects recruited from 2 separate centers underwent detailed clinical assessment, sputum induction, and phlebotomy. One hundred three clinical, physiologic, and inflammatory parameters were analyzed by using topological data analysis and Bayesian network analysis.Severe asthma was associated with anxiety and depression, obesity, sinonasal symptoms, decreased quality of life, and inflammatory changes, including increased sputum chitinase 3-like protein 1 (YKL-40) and matrix metalloproteinase (MMP) 1, 3, 8, and 12 levels. Topological data analysis identified 6 clinicopathobiologic clusters replicated in both geographic cohorts: young, mild paucigranulocytic; older, sinonasal disease; obese, high MMP levels; steroid resistant TH2 mediated, eosinophilic; mixed granulocytic with severe obstruction; and neutrophilic, low periostin levels, severe obstruction. Sputum IL-5 levels were increased in patients with severe particularly eosinophilic forms, whereas IL-13 was suppressed and IL-17 levels did not differ between clusters. Bayesian network analysis separated clinical features from intricately connected inflammatory pathways. YKL-40 levels strongly correlated with neutrophilic asthma and levels of myeloperoxidase, IL-8, IL-6, and IL-6 soluble receptor. MMP1, MMP3, MMP8, and MMP12 levels were associated with severe asthma and were correlated positively with sputum IL-5 levels but negatively with IL-13 levels.In 2 distinct cohorts we have identified and replicated 6 clinicopathobiologic clusters based on blood and induced sputum measures. Our data underline a disconnect between clinical features and underlying inflammation, suggest IL-5 production is relatively steroid insensitive, and highlight the expression of YKL-40 in patients with neutrophilic inflammation and the expression of MMPs in patients with severe asthma. |
| first_indexed | 2024-03-06T22:24:32Z |
| format | Journal article |
| id | oxford-uuid:5637db2d-be9f-4589-97f2-162bd489c9b8 |
| institution | University of Oxford |
| language | English |
| last_indexed | 2024-03-06T22:24:32Z |
| publishDate | 2016 |
| publisher | Elsevier |
| record_format | dspace |
| spelling | oxford-uuid:5637db2d-be9f-4589-97f2-162bd489c9b82022-03-26T16:49:02ZMultidimensional endotyping in patients with severe asthma reveals inflammatory heterogeneity in matrix metalloproteinases and chitinase 3–like protein 1Journal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:5637db2d-be9f-4589-97f2-162bd489c9b8EnglishSymplectic Elements at OxfordElsevier2016Hinks, TBrown, TLau, LRupani, HBarber, CElliott, SWard, JOno, JOhta, SIzuhara, KDjukanović, RKurukulaaratchy, RChauhan, AHowarth, PDisease heterogeneity in patients with severe asthma and its relationship to inflammatory mechanisms remain poorly understood.We aimed to identify and replicate clinicopathologic endotypes based on analysis of blood and sputum parameters in asthmatic patients.One hundred ninety-four asthmatic patients and 21 control subjects recruited from 2 separate centers underwent detailed clinical assessment, sputum induction, and phlebotomy. One hundred three clinical, physiologic, and inflammatory parameters were analyzed by using topological data analysis and Bayesian network analysis.Severe asthma was associated with anxiety and depression, obesity, sinonasal symptoms, decreased quality of life, and inflammatory changes, including increased sputum chitinase 3-like protein 1 (YKL-40) and matrix metalloproteinase (MMP) 1, 3, 8, and 12 levels. Topological data analysis identified 6 clinicopathobiologic clusters replicated in both geographic cohorts: young, mild paucigranulocytic; older, sinonasal disease; obese, high MMP levels; steroid resistant TH2 mediated, eosinophilic; mixed granulocytic with severe obstruction; and neutrophilic, low periostin levels, severe obstruction. Sputum IL-5 levels were increased in patients with severe particularly eosinophilic forms, whereas IL-13 was suppressed and IL-17 levels did not differ between clusters. Bayesian network analysis separated clinical features from intricately connected inflammatory pathways. YKL-40 levels strongly correlated with neutrophilic asthma and levels of myeloperoxidase, IL-8, IL-6, and IL-6 soluble receptor. MMP1, MMP3, MMP8, and MMP12 levels were associated with severe asthma and were correlated positively with sputum IL-5 levels but negatively with IL-13 levels.In 2 distinct cohorts we have identified and replicated 6 clinicopathobiologic clusters based on blood and induced sputum measures. Our data underline a disconnect between clinical features and underlying inflammation, suggest IL-5 production is relatively steroid insensitive, and highlight the expression of YKL-40 in patients with neutrophilic inflammation and the expression of MMPs in patients with severe asthma. |
| spellingShingle | Hinks, T Brown, T Lau, L Rupani, H Barber, C Elliott, S Ward, J Ono, J Ohta, S Izuhara, K Djukanović, R Kurukulaaratchy, R Chauhan, A Howarth, P Multidimensional endotyping in patients with severe asthma reveals inflammatory heterogeneity in matrix metalloproteinases and chitinase 3–like protein 1 |
| title | Multidimensional endotyping in patients with severe asthma reveals inflammatory heterogeneity in matrix metalloproteinases and chitinase 3–like protein 1 |
| title_full | Multidimensional endotyping in patients with severe asthma reveals inflammatory heterogeneity in matrix metalloproteinases and chitinase 3–like protein 1 |
| title_fullStr | Multidimensional endotyping in patients with severe asthma reveals inflammatory heterogeneity in matrix metalloproteinases and chitinase 3–like protein 1 |
| title_full_unstemmed | Multidimensional endotyping in patients with severe asthma reveals inflammatory heterogeneity in matrix metalloproteinases and chitinase 3–like protein 1 |
| title_short | Multidimensional endotyping in patients with severe asthma reveals inflammatory heterogeneity in matrix metalloproteinases and chitinase 3–like protein 1 |
| title_sort | multidimensional endotyping in patients with severe asthma reveals inflammatory heterogeneity in matrix metalloproteinases and chitinase 3 like protein 1 |
| work_keys_str_mv | AT hinkst multidimensionalendotypinginpatientswithsevereasthmarevealsinflammatoryheterogeneityinmatrixmetalloproteinasesandchitinase3likeprotein1 AT brownt multidimensionalendotypinginpatientswithsevereasthmarevealsinflammatoryheterogeneityinmatrixmetalloproteinasesandchitinase3likeprotein1 AT laul multidimensionalendotypinginpatientswithsevereasthmarevealsinflammatoryheterogeneityinmatrixmetalloproteinasesandchitinase3likeprotein1 AT rupanih multidimensionalendotypinginpatientswithsevereasthmarevealsinflammatoryheterogeneityinmatrixmetalloproteinasesandchitinase3likeprotein1 AT barberc multidimensionalendotypinginpatientswithsevereasthmarevealsinflammatoryheterogeneityinmatrixmetalloproteinasesandchitinase3likeprotein1 AT elliotts multidimensionalendotypinginpatientswithsevereasthmarevealsinflammatoryheterogeneityinmatrixmetalloproteinasesandchitinase3likeprotein1 AT wardj multidimensionalendotypinginpatientswithsevereasthmarevealsinflammatoryheterogeneityinmatrixmetalloproteinasesandchitinase3likeprotein1 AT onoj multidimensionalendotypinginpatientswithsevereasthmarevealsinflammatoryheterogeneityinmatrixmetalloproteinasesandchitinase3likeprotein1 AT ohtas multidimensionalendotypinginpatientswithsevereasthmarevealsinflammatoryheterogeneityinmatrixmetalloproteinasesandchitinase3likeprotein1 AT izuharak multidimensionalendotypinginpatientswithsevereasthmarevealsinflammatoryheterogeneityinmatrixmetalloproteinasesandchitinase3likeprotein1 AT djukanovicr multidimensionalendotypinginpatientswithsevereasthmarevealsinflammatoryheterogeneityinmatrixmetalloproteinasesandchitinase3likeprotein1 AT kurukulaaratchyr multidimensionalendotypinginpatientswithsevereasthmarevealsinflammatoryheterogeneityinmatrixmetalloproteinasesandchitinase3likeprotein1 AT chauhana multidimensionalendotypinginpatientswithsevereasthmarevealsinflammatoryheterogeneityinmatrixmetalloproteinasesandchitinase3likeprotein1 AT howarthp multidimensionalendotypinginpatientswithsevereasthmarevealsinflammatoryheterogeneityinmatrixmetalloproteinasesandchitinase3likeprotein1 |